Inflammatory markers of outcome

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology
• Biomarker Research

Background:

• A significant portion of early childhood wheezing may not stem from atopy-induced pulmonary inflammation.
• Existing mediator studies in adults and older children might not be applicable to the unique physiology of young children.
• The utility of inflammatory markers in young children hinges on distinct inflammation patterns in atopic versus nonatopic wheezing and the accuracy of indirect measurements.

Purpose of the Study:

• To investigate the relationship between atopic status and pulmonary inflammation patterns in early childhood wheezing.
• To assess the validity of indirect plasma-based inflammatory markers for reflecting the lung's inflammatory environment.
• To explore the potential of bronchoalveolar lavage (BAL) and specific plasma mediators in characterizing childhood wheezing.

Main Methods:

• Utilized bronchoalveolar lavage (BAL) to directly sample the alveolar milieu for mediator profiling.
• Measured eosinophil cationic protein (ECP) concentrations in BAL fluid (BALF) to assess pulmonary eosinophil activation.
• Analyzed BALF interleukin-2 to interleukin-4 ratio for identifying pulmonary sensitization.
• Correlated plasma concentrations of eosinophil-specific mediators (ECP, eosinophil protein X [EPX], major basic protein [MBP]) and adhesion molecules with atopy-induced wheezing.

Main Results:

• BALF ECP concentrations accurately reflect pulmonary eosinophil activation.
• The BALF interleukin-2 to interleukin-4 ratio may help identify children with established pulmonary sensitization.
• Plasma ECP, EPX, and MBP correlate with atopy-induced wheezing, but systemic atopic activation can also elevate these markers.
• The diagnostic potential of plasma adhesion molecules (e.g., soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, E-selectin) for defining pulmonary inflammation remains unclear.

Conclusions:

• Bronchoalveolar lavage is a valuable tool for assessing pulmonary inflammation and validating plasma markers in young children.
• Specific BALF mediators can help differentiate types of wheezing and identify sensitization.
• Further research is needed to clarify the role of plasma markers, including adhesion molecules, in characterizing early childhood pulmonary inflammation.